SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 194 filers reported holding SEATTLE GENETICS INC in Q2 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $34,000 | +47.8% | 200 | 0.0% | 0.00% | – |
Q1 2020 | $23,000 | -72.9% | 200 | -80.0% | 0.00% | – |
Q3 2019 | $85,000 | +23.2% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $69,000 | -37.3% | 1,000 | -33.3% | 0.00% | – |
Q1 2019 | $110,000 | -54.4% | 1,500 | -64.7% | 0.00% | – |
Q4 2018 | $241,000 | +213.0% | 4,250 | +325.0% | 0.00% | – |
Q3 2018 | $77,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2018 | $66,000 | +26.9% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $52,000 | -3.7% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $54,000 | +237.5% | 1,000 | +233.3% | 0.00% | – |
Q3 2017 | $16,000 | -33.3% | 300 | -50.0% | 0.00% | – |
Q2 2016 | $24,000 | +14.3% | 600 | 0.0% | 0.00% | – |
Q1 2016 | $21,000 | +162.5% | 600 | +200.0% | 0.00% | – |
Q3 2015 | $8,000 | -20.0% | 200 | 0.0% | 0.00% | – |
Q2 2015 | $10,000 | -65.5% | 200 | -77.6% | 0.00% | – |
Q4 2014 | $29,000 | -12.1% | 891 | 0.0% | 0.00% | – |
Q3 2014 | $33,000 | -2.9% | 891 | 0.0% | 0.00% | – |
Q2 2014 | $34,000 | +100.0% | 891 | +133.9% | 0.00% | – |
Q1 2014 | $17,000 | +54.5% | 381 | +36.1% | 0.00% | – |
Q4 2013 | $11,000 | -8.3% | 280 | 0.0% | 0.00% | – |
Q3 2013 | $12,000 | -62.5% | 280 | -72.0% | 0.00% | – |
Q2 2013 | $32,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |